Fabiana de Faria Ghetti1,2, Daiane Gonçalves Oliveira3, Juliano Machado de Oliveira3, Lincoln Eduardo Villela Vieira de Castro Ferreira3, Dionéia Evangelista Cesar4, Ana Paula Boroni Moreira5. 1. Universitary Hospital and School of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil. bia.ghetti@hotmail.com. 2. Unidade de Nutrição Clínica, Hospital Universitário, Rua Catulo Breviglieri, s/n, Bairro Santa Catarina, Juiz de Fora, Minas Gerais, CEP 36036-330, Brazil. bia.ghetti@hotmail.com. 3. Universitary Hospital and School of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil. 4. Department of Biology, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil. 5. Department of Nutrition, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Abstract
INTRODUCTION: Nonalcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflammation, and ballooning degeneration of hepatocytes, with or without fibrosis. The prevalence of NASH has increased with the obesity epidemic, but its etiology is multifactorial. The current studies suggest the role of gut microbiota in the development and progression of NASH. The aim is to review the studies that investigate the relationship between gut microbiota and NASH. These review also discusses the pathophysiological mechanisms and the influence of diet on the gut-liver axis. RESULT: The available literature has proposed mechanisms for an association between gut microbiota and NASH, such as: modification energy homeostasis, lipopolysaccharides (LPS)-endotoxemia, increased endogenous production of ethanol, and alteration in the metabolism of bile acid and choline. There is evidence to suggest that NASH patients have a higher prevalence of bacterial overgrowth in the small intestine and changes in the composition of the gut microbiota. However, there is still a controversy regarding the microbiome profile in this population. The abundance of Bacteroidetes phylum may be increased, decreased, or unaltered in NASH patients. There is an increase in the Escherichia and Bacteroides genus. There is depletion of certain taxa, such as Prevotella and Faecalibacterium. CONCLUSION: Although few studies have evaluated the composition of the gut microbiota in patients with NASH, it is observed that these individuals have a distinct gut microbiota, compared to the control groups, which explains, at least in part, the genesis and progression of the disease through multiple mechanisms. Modulation of the gut microbiota through diet control offers new challenges for future studies.
INTRODUCTION:Nonalcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflammation, and ballooning degeneration of hepatocytes, with or without fibrosis. The prevalence of NASH has increased with the obesity epidemic, but its etiology is multifactorial. The current studies suggest the role of gut microbiota in the development and progression of NASH. The aim is to review the studies that investigate the relationship between gut microbiota and NASH. These review also discusses the pathophysiological mechanisms and the influence of diet on the gut-liver axis. RESULT: The available literature has proposed mechanisms for an association between gut microbiota and NASH, such as: modification energy homeostasis, lipopolysaccharides (LPS)-endotoxemia, increased endogenous production of ethanol, and alteration in the metabolism of bile acid and choline. There is evidence to suggest that NASH patients have a higher prevalence of bacterial overgrowth in the small intestine and changes in the composition of the gut microbiota. However, there is still a controversy regarding the microbiome profile in this population. The abundance of Bacteroidetes phylum may be increased, decreased, or unaltered in NASH patients. There is an increase in the Escherichia and Bacteroides genus. There is depletion of certain taxa, such as Prevotella and Faecalibacterium. CONCLUSION: Although few studies have evaluated the composition of the gut microbiota in patients with NASH, it is observed that these individuals have a distinct gut microbiota, compared to the control groups, which explains, at least in part, the genesis and progression of the disease through multiple mechanisms. Modulation of the gut microbiota through diet control offers new challenges for future studies.
Entities:
Keywords:
Dysbiosis; Gut microbiota; Microbiome; Nonalcoholic fatty liver disease; Steatohepatitis
Authors: T Nosova; K Jokelainen; P Kaihovaara; H Jousimies-Somer; A Siitonen; R Heine; M Salaspuro Journal: Alcohol Alcohol Date: 1996-11 Impact factor: 2.826
Authors: Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon Journal: Proc Natl Acad Sci U S A Date: 2007-01-08 Impact factor: 11.205
Authors: Diana M Shih; Zeneng Wang; Richard Lee; Yonghong Meng; Nam Che; Sarada Charugundla; Hannah Qi; Judy Wu; Calvin Pan; J Mark Brown; Thomas Vallim; Brian J Bennett; Mark Graham; Stanley L Hazen; Aldons J Lusis Journal: J Lipid Res Date: 2014-11-06 Impact factor: 5.922
Authors: Richard Kirsch; Vivian Clarkson; Robert C Verdonk; Adrian D Marais; Enid G Shephard; Bernard Ryffel; Pauline de la M Hall Journal: J Gastroenterol Hepatol Date: 2006-01 Impact factor: 4.029
Authors: Jelena Anastasovska; Tulika Arora; Gina J Sanchez Canon; James R C Parkinson; Kieran Touhy; Glen R Gibson; Nachiket A Nadkarni; Po-Wah So; Anthony P Goldstone; E Louise Thomas; Mohammed K Hankir; Jan Van Loo; Neena Modi; Jimmy D Bell; Gary Frost Journal: Obesity (Silver Spring) Date: 2012-01-17 Impact factor: 5.002
Authors: Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis Journal: Science Date: 2011-09-01 Impact factor: 47.728
Authors: Vincenzina Fusco; Grazia M Quero; Gyu-Sung Cho; Jan Kabisch; Diana Meske; Horst Neve; Wilhelm Bockelmann; Charles M A P Franz Journal: Front Microbiol Date: 2015-03-17 Impact factor: 5.640
Authors: Marc R Bomhof; Jill A Parnell; Hena R Ramay; Pam Crotty; Kevin P Rioux; Chris S Probert; Saumya Jayakumar; Maitreyi Raman; Raylene A Reimer Journal: Eur J Nutr Date: 2018-05-19 Impact factor: 5.614
Authors: Bejan J Saeedi; Ken H Liu; Joshua A Owens; Sarah Hunter-Chang; Mary C Camacho; Richard U Eboka; Bindu Chandrasekharan; Nusaiba F Baker; Trevor M Darby; Brian S Robinson; Rheinallt M Jones; Dean P Jones; Andrew S Neish Journal: Cell Metab Date: 2020-03-25 Impact factor: 27.287
Authors: Francesco Baratta; Daniele Pastori; Simona Bartimoccia; Vittoria Cammisotto; Nicholas Cocomello; Alessandra Colantoni; Cristina Nocella; Roberto Carnevale; Domenico Ferro; Francesco Angelico; Francesco Violi; Maria Del Ben Journal: Nutrients Date: 2020-06-10 Impact factor: 5.717
Authors: Peter Christopher Konturek; Igor Alexander Harsch; Kathrin Konturek; Monic Schink; Thomas Konturek; Markus F Neurath; Yurdaguel Zopf Journal: Med Sci (Basel) Date: 2018-09-17